HOOKIPA BIOTECH CLOSES €20 MILLION ($27.5 MILLION) IN SERIES B FINANCING Funds to be used to progress viral vaccine pipeline and to explore applications in cancer immunotherapy VIENNA, AUSTRIA, November 4, [removed]Hooki

Source URL: www.hookipabiotech.com

• Sofinnova
• Venture capital
• Boehringer Ingelheim
• Private equity
• Vaccine
• Jean Deleage
• Financial economics
• Investment
• Finance

Microsoft Word - Hookipa Biotech wins ViE Best Financing Deal Award - 28March2014 - draft.docx

Source URL: www.hookipabiotech.com

• Vaccine
• Virology
• Sofinnova
• Viral vector
• Biology
• Vaccination
• Microbiology

ARM APPROVED - Crocus licenses MLUT technology to ARM

Source URL: www.sofinnova.com

• Computing
• Crocus Technology
• Non-volatile memory
• Emerging technologies
• Semiconductor companies
• Microcontroller
• Magnetoresistive random access memory
• Random-access memory
• Crocus
• Computer hardware
• Computer memory
• Electronics

as scientific advisors, including Katherine High, a gene therapy is inc pioneer who served as the director of the CCMT since its at So inception. demo

Source URL: www.sofinnova.com

• Emerging technologies
• Gene delivery
• Medical genetics
• Medical research
• Gene therapy
• Biosimilar
• Sofinnova
• Pfizer
• Spark
• Biology
• Biotechnology
• Medicine

Sofinnova Ventures Leads $57M Financing for NuCana BioMed Brian Gormley April 10, 2014 Sofinnova Ventures is leading a $57 million financing for NuCana BioMed Ltd ., which is developing better versions of existing chemot

Source URL: www.sofinnova.com

• Organofluorides
• Sofinnova
• Targeted therapy
• Chemotherapy
• Daniel Von Hoff
• Medicine
• Eli Lilly and Company
• Gemcitabine

PDF Document

Source URL: www.sofinnova.com